Zydus Wellness registers 20 percent net sales growth in Q1
Advertisement
Ahmedabad: For the first quarter ended June 30, 2024, Zydus Wellness Ltd., recorded its highest ever Q1 net sales growth of 20 percent which stood at Rs. 8,391 million y-o-y. The Company registered growth in EBIDTA of 33.3% y-o-y basis to Rs. 1,553 million. Net profit for the quarter grew by 33.8% and stood at Rs. 1,477 million. Adjusted PAT grew by 39.6% y-o-y after eliminating exceptional items and one-time deferred tax assets from the comparable quarter of the previous year. During the quarter, the Company repaid its debt in full, thus de-leveraging its balance sheet and yet retaining its strong cash position at the quarter end.
During the quarter, the Company’s products posted excellent growth with its brands Glucon D, Nycil, Everyuth Peel-off and Scrub.
As the country faced a prolonged and intensive summer, the Glucose powder category grew by 21.3%*. Glucon-D continued to maintain its number one position with 59.7%* market share according to a release.
The brand penetration of Glucon-D increased by 160 basis points vs. last year. The sugar substitute category grew by 5.8%*. Sugar Free Green continues to experience strong double-digit growth driven by increasing volume uptake. Offering an aspartame free alternative, the Company has launched Sugar Free Gold+, a new formulation comprising sucralose and chromium, which helps maintain normal blood glucose levels.
I’Mlite, a unique formulation of sugar blended with stevia offers consumers 50% less calories than regular sugar. The product has gained a positive response in the market. The Everyuth brand holds the fifth 5 position with a 6.6%* market share in the overall facial cleansing segment level. In the Peel-off category which grew by 21.1%*, Everyuth Peel-off has a market share of 78.2%*, an increase of 200 basis points over the same period last year. Everyuth Scrub has a market share of 46.2%* in the facial scrub category, an increase of 373 basis points over the same period last year. During the quarter, the Company expanded its facial cleansing range with the launch of Everyuth pink clay & charcoal infused anti-pollution face wash, scrub and face pack.
Nycil, buoyed by the summer demand, recorded a consistent increase in household penetration in line with the Company's strategy of recruiting new consumers, maintained its number one position with a market share of 34.9%* in the prickly heat powder category. The Company also launched a range of soaps under the Nycil brand in the international markets.
The Health Foods Drink Category has registered a growth of 4.3%*. Complan’s market share stood at 4.3%*. Besides, Complan forayed into the immunity boosting beverage space with the launch of Complan Immuno-Gro in select states.
During the quarter, the Company also launched Nutralite professional mayonnaise with tandoori range and Nutralite retail mayonnaise with carrot and cucumber sandwich.
Read also: Zydus Lifesciences gets Mexican marketing approval for Mamitra to treat various cancers
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.